However, EGFR mutant lung cancers exhibit myeloid cell recruitment, but no CD8+ immune response was observed, suggesting that EGFR mutations may not be able to generate a sufficient antigen-driven immune response (10). The gene discussed is EGFR; the disease is lung carcinoma.